This site is intended for Healthcare Professionals only.

Tag: Association of the British Pharmaceutical Industry

spot_imgspot_img

Over 100 medicines are currently in short supply, warns BGMA

Reducing disruptions to the movement of medicines around the world is “absolutely critical” for maintaining supply resilience in the UK, ABPI has suggested.   The...

DHSC publishes 2024 Voluntary Scheme agreement text

The new VPAG scheme will save the NHS £14 billion over five years in medicines costs   The Department of Health and Social Care (DHSC)...

New VPAG scheme to save NHS £14 billion

The level of annual allowed growth in sales of branded medicines will double from two per cent per year in 2024 to four per...

No medicines contracts for suppliers who do not submit evergreen assessment from 2024, says NHSE

The introduction of the evergreen assessment is part of NHS England's ambition to reach carbon net zero by 2045  Starting from January 2024, it will be...

ABPI reports ‘steady positive trend’ of public trust in pharma industry

The UK pharmaceutical industry experienced a substantial increase in public trust and favourability during the Covid-19 pandemic, according to a new poll. This trend...

‘One year on, no medicine has entered NHSE’s Innovative Medicines Fund’

The NHS England(NHSE) Innovative Medicines Fund (IMF) should be efficiently utilised to expedite patient access to potentially valuable new medications, thereby incentivising the pharmaceutical...